Literature DB >> 6819076

Maintenance of normocalcemia by continuous infusion of the synthetic bovine parathyroid hormone (1-34) in parathyroidectomized rats.

M M Ibrahim, L R Forte, M L Thomas.   

Abstract

This work was conducted to estimate the replacement dose of the synthetic bovine parathyroid hormone [PTH(1-34)] that is required for maintenance of serum calcium (Ca) in parathyroidectomized (PTX) rats. Male rats were PTX and used in this study only if serum Ca was reduced to at least 7 mg/dl. We found that a solution of 2% cysteine, 150 mM NaCl, and 1 mM HCL was superior to 20 mM acetic acid for maintenance of biological activity of PTH (1-34) in situ during the period of hormone infusion studied. The PTH dose-calcemic response relationship was investigated using PTH in doses of 0.6, 1, and 3 U/h. The infusion of 1 U PTH per hour raised Ca to the normal level, whereas rats infused with 0.6 U/h were hypocalcemic and 3 U/h resulted in marked hypercalcemia. To extend this observation we carried out an infusion of 1 U PTH per hour for 14 days. We found that this infusion rate of bovine PTH (1-34) provided a relatively stable level of serum calcium with modest fluctuation from normocalcemic to somewhat hypercalcemic levels for the entire 14-day period of PTH infusion. Serum calcitonin was also elevated during the infusion period and then returned to the initial level when PTH treatment was stopped. After the minipumps containing PTH were removed, the serum Ca dropped rapidly to 5 mg/dl, which was significantly lower than the control (vehicle-infused) or initial values of serum Ca (7 mg/dl). Infusion of PTH at 3 U/h for 4 days did not produce this rebound hypocalcemia after the pumps were removed. Serum Ca in those experiments returned to the initial level after hormone treatment was discontinued.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6819076     DOI: 10.1007/bf02411303

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  13 in total

1.  Parathyroid hormone-mediated refractoriness of rat kidney cyclic AMP system.

Authors:  G A Nickols; D L Carnes; C S Anast; L R Forte
Journal:  Am J Physiol       Date:  1979-04

2.  A method for determination of parathyroid secretion rate in the rat.

Authors:  B N PREMACHANDRA; H T BLUMENTHAL
Journal:  Proc Soc Exp Biol Med       Date:  1961 Aug-Sep

Review 3.  The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. II. PTH and bone cells: bone turnover and plasma calcium regulation.

Authors:  A M Parfitt
Journal:  Metabolism       Date:  1976-08       Impact factor: 8.694

4.  An estimation of the parathyroid hormone secretion rate in vitamin D deficient rats.

Authors:  H Takahashi; E Shimazawa; N Horiuchi; T Suda; K Yamashita; E Ogata
Journal:  Horm Metab Res       Date:  1978-03       Impact factor: 2.936

5.  Relative biologic activities of human and bovine parathyroid hormones and their synthetic, NH2-terminal (1-34) peptides, as evaluated in vitro with renal cortical adenylate cyclase obtained from three different species.

Authors:  F P Di Bella; C D Arnaud; H B Brewer
Journal:  Endocrinology       Date:  1976-08       Impact factor: 4.736

6.  Loss of calcemic effects of calcitonin and parathyroid hormone infused continuously into rats using the Alzet osmotic minipump.

Authors:  J F Obie; C W Cooper
Journal:  J Pharmacol Exp Ther       Date:  1979-06       Impact factor: 4.030

7.  Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity.

Authors:  G W Tregear; J Van Rietschoten; E Greene; H T Keutmann; H D Niall; B Reit; J A Parsons; J T Potts
Journal:  Endocrinology       Date:  1973-12       Impact factor: 4.736

8.  Isolation and characterization of the bovine parathyroid isohormones.

Authors:  H T Keutmann; G D Aurbach; B F Dawson; H D Niall; L J Deftos; J T Potts
Journal:  Biochemistry       Date:  1971-07-06       Impact factor: 3.162

9.  Serum calcitonin-lowering effect of magnesium in patients with medullary carcinoma of the thyroid.

Authors:  C Anast; L David; J Winnacker; R Glass; W Baskin; L Brubaker; T Burns
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

10.  In vitro studies of the adenosine 3',5'-monophosphate (cAMP) response of embryonic rat calvaria to bovine parathyroid hormone-(1--84) [bPTH-(1--84)], BPTH-(1--34), and bPTH-(3--34) and the loss of cAMP responsiveness after prolonged incubation.

Authors:  M P Herrmann-Erlee; J M van der Meer; J W Hekkelman
Journal:  Endocrinology       Date:  1980-06       Impact factor: 4.736

View more
  3 in total

1.  Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats.

Authors:  A F Stewart; M Mangin; T Wu; D Goumas; K L Insogna; W J Burtis; A E Broadus
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

2.  PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor.

Authors:  Alexandre Loupy; Suresh Krishna Ramakrishnan; Bharath Wootla; Régine Chambrey; Renaud de la Faille; Soline Bourgeois; Patrick Bruneval; Chantal Mandet; Erik Ilso Christensen; Hélène Faure; Lydie Cheval; Kamel Laghmani; Corinne Collet; Dominique Eladari; Robert H Dodd; Martial Ruat; Pascal Houillier
Journal:  J Clin Invest       Date:  2012-08-13       Impact factor: 14.808

3.  Glucocorticoids possess calcitonin-like antihypercalcemic properties in rats.

Authors:  P F Hirsch; Y Imai; Y Hosoya; H Ode; S Maeda
Journal:  Endocrine       Date:  1998-02       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.